physIQ announced Jason Luke has been appointed to the company’s Medical Advisory Board.
Canary Medical announced the appointment of Lisa Suennen as President, Digital and Data Solutions.
Emmes has expanded capabilities in India during the last two years and has seen surging growth in the region, with local revenue increasing by 400% and global study revenue increasing by more than 50%.
ACTO has been recognized as a Trailblazer in Life Sciences Commercial Analytics and Artificial Intelligence by Everest Group.
eClinical Solutions announced its accreditation in Medidata’s Site Cloud: End of Study platform.
The Almac Group has pledged to be net zero by 2045.
Quanticate announced plans for further expansion and new jobs in Toronto in 2023 as it thrives post-pandemic after it opened the office in 2019.
physIQ announced that OncoBay Clinical, Inc., has joined its Intrepid Partner Program.
Elligo Health Research just won the Fast 50 Award, sponsored by the Austin Business Journal.
Jumo Health announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.
AeroSafe Global announced that it earned the No. 1 spot on the 2022 Top 100 list of fast-growing, privately owned companies in the Rochester and Finger Lakes region.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.